Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05012735 · ClinicalTrials.gov registry record · Phase 1
A Study of a Hydrocolloid Bandage on Pimples
A Phase 1 study, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- Completed
- Registry status
- Phase 1
- Development phase
- 41
- Enrollment target
NCT05012735 is a Phase 1 study that has completed, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 41 participants.
The verdict
NCT05012735, a Phase 1 study, has completed, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness and tolerability of a hydrocolloid bandage on pimples when used overnight for one week.
Interventions
- DRUG Study Cleanser (Neutrogena Ultra Gentle Daily Cleanser with Pro Vitamin B5)
- DEVICE Prototype Ultrathin Hydrocolloid Bandage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2021-07-19 |
| Est. Completion | 2021-09-13 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05012735
The ClinicalTrials.gov registry entry for NCT05012735 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Study Cleanser (Neutrogena Ultra Gentle Daily Cleanser with Pro Vitamin B5) is the first listed.
NCT05012735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05012735 about?
NCT05012735 is a clinical study titled "A Study of a Hydrocolloid Bandage on Pimples". The purpose of this study is to evaluate the effectiveness and tolerability of a hydrocolloid bandage on pimples when used overnight for one week.
What is the current status of trial NCT05012735?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 41 participants. The study started on 2021-07-19. Estimated completion is 2021-09-13.
What interventions are being tested in trial NCT05012735?
The interventions under investigation include: Study Cleanser (Neutrogena Ultra Gentle Daily Cleanser with Pro Vitamin B5) (DRUG), Prototype Ultrathin Hydrocolloid Bandage (DEVICE).
Who is sponsoring clinical trial NCT05012735?
This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.